Revance – Talk Bio

Actionable Insights Powered by AI

Revance Therapeutics Faces Competing Buyout Offers: Teoxane SA Outbids Crown Laboratories

4 months ago talkbio0Tagged Biotechnology, Crown Laboratories, Industry, Revance, sulfanilamide, Teoxane

Revance Therapeutics, Teoxane SA, Crown Laboratories, buyout offers, merger agreement, biotechnology, skincare industry

Crown Laboratories to Acquire Botox Rival Revance Therapeutics for $924M

8 months ago talkbio0Tagged Acquisition (action), Botox Rival, Crown Laboratories, Daxxify, Private Room, Revance, skincare

Crown Laboratories, Revance Therapeutics, Botox rival, Daxxify, acquisition, private deal, skincare company